Understanding the Link Between Gut Health and Disease

Dr. Sabine Hazan discusses dysbiosis of the gut microbiota and explains how microbiome targeting therapies have the potential to treat countless conditions as well as success with "refloralization."

Dr. Sabine Hazan

Dr. Hazan is the founder of Ventura Clinical Trials, and has been Principal Investigator and Sub Investigator in over 150 clinical trials. Many of these trials were for Clostridioides difficile infection (CDI), enough that through her impressive recruitment she became known as the Queen of C. difficile in the clinical trial community. When her patients with C.diff did not respond to traditional or clinical trial therapies, she resorted to treatment via fecal microbiota transplant (FMT), which she later coined refloralization™. She is the author of Let's Talk Sh!t, a humorous, easy to digest explanation of gastrointestinal disorders, treatments, and next generation hope for gut-related diseases. Her GI treatments have proven to help Covid patients survive.

Q: